BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36795581)

  • 1. An Introduction to the Japanese Immunization Program: Past, Present, and Future Perspectives.
    Kamiya H; Kamidani S; Saitoh A
    Pediatr Infect Dis J; 2023 May; 42(5):e154-e157. PubMed ID: 36795581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and challenges for the Japanese immunization program: Beyond the "vaccine gap".
    Saitoh A; Okabe N
    Vaccine; 2018 Jul; 36(30):4582-4588. PubMed ID: 29929825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pressing issues and future plans for immunization practice in Japan].
    Nakayama T
    Nihon Rinsho; 2008 Oct; 66(10):1851-7. PubMed ID: 18939481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap.
    Saitoh A; Okabe N
    Vaccine; 2021 May; 39(22):3018-3024. PubMed ID: 33931250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acellular pertussis vaccines in Japan: past, present and future.
    Watanabe M; Nagai M
    Expert Rev Vaccines; 2005 Apr; 4(2):173-84. PubMed ID: 15889991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current issues with the immunization program in Japan: can we fill the "vaccine gap"?
    Saitoh A; Okabe N
    Vaccine; 2012 Jul; 30(32):4752-6. PubMed ID: 22521841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress and concerns regarding the Japanese immunization program: addressing the "vaccine gap".
    Saitoh A; Okabe N
    Vaccine; 2014 Jul; 32(34):4253-8. PubMed ID: 24951864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
    De Waure C; Sisti LG; Poscia A; Ricciardi W
    Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
    Sutter RW; Prevots DR; Cochi SL
    Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of immunization systems in Japan and the United States - What can be learned?
    Katsuta T; Moser CA; Feemster KA; Saitoh A; Offit PA
    Vaccine; 2020 Oct; 38(46):7401-7408. PubMed ID: 33004240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues with infectious disease vaccine introduction into routine vaccination in Japan, and considerations for accelerating the process.
    Okumoto A; Nomura Y; Okuda S; Shikano M
    Vaccine; 2024 Feb; 42(4):987-994. PubMed ID: 38199920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
    Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
    Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP).
    National Center for Immunization and Respiratory Diseases
    MMWR Recomm Rep; 2011 Jan; 60(2):1-64. PubMed ID: 21293327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resumption of active recommendation of the human papillomavirus vaccine in Japan and future challenges for the National Immunization Program.
    Ujiie M
    Hum Vaccin Immunother; 2022 Nov; 18(6):2090777. PubMed ID: 35767827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-related adverse events in Cuban children, 1999-2008.
    Galindo BM; Concepción D; Galindo MA; Pérez A; Saiz J
    MEDICC Rev; 2012 Jan; 14(1):38-43. PubMed ID: 22334111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of hepatitis B immunization in the Expanded Program on Immunization of the Child Survival Project.
    Mansour E; Abdul-Rahim S; Batouty G; Zaghloul I; Abdel-Hadi S
    J Egypt Public Health Assoc; 1993; 68(5-6):487-94. PubMed ID: 7775876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of varicella vaccine in Japan and future prospects.
    Ozaki T; Asano Y
    Vaccine; 2016 Jun; 34(29):3427-33. PubMed ID: 27160039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella vaccination in Japan: necessity of implementing a routine vaccination program.
    Ozaki T
    J Infect Chemother; 2013 Apr; 19(2):188-95. PubMed ID: 23483311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.